| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |